Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Ixaconazole Impurity31

Ixaconazole Impurity31 is listed in the pharmaceutical impurity collection under CAS 40805-50-3. Its represented structure has formula C9H6ClNO and a calculated molecular weight of 179.61 g/mol.

2D chemical structure

N O C l

Chemical identity

Catalog name
Ixaconazole Impurity31
Common name
Ixaconazole Impurity31
Chemical name
4-(2-chloroacetyl)benzonitrile
CAS
40805-50-3
SMILES
N#Cc1ccc(C(=O)CCl)cc1
InChI
InChI=1S/C9H6ClNO/c10-5-9(12)8-3-1-7(6-11)2-4-8/h1-4H,5H2
InChIKey
LDHNCFIXYHXVDN-UHFFFAOYSA-N
Associated API
Ixaconazole

Record ID: A697c5ca58ac1

Computed properties

C9H6ClNO Molecular formula
179.606 g/molMolecular weight
179.0138 DaMonoisotopic exact mass
40.86 ŲTopological polar surface area
1.9798 Calculated LogP (Wildman–Crippen)
46.2075 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 2 4 6 8 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight179.60612.36
Calculated LogP (Wildman–Crippen)1.979842.28
Topological polar surface area40.8622.92
Hydrogen-bond acceptors215.92
Hydrogen-bond donors011.28
Rotatable bonds (strict)224.16

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC9H6ClNOdimensionless
Molecular weight179.606g/mol
Monoisotopic exact mass179.0138Da
Topological polar surface area40.86Ų
Calculated LogP (Wildman–Crippen)1.9798dimensionless
Molar refractivity (Wildman–Crippen)46.2075cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors0count
Rotatable bonds (strict)2count
Heavy atoms12count
Heteroatoms3count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.1111fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area75.3836Ų
Valence electrons60count
Radical electrons0count
Bertz complexity323.3769index
Balaban J2.938index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Ixaconazole Impurity31

Qualification and safety assessment of Ixaconazole Impurity31

Explore toxicological qualification of Ixaconazole Impurity31 and ICH M7 mutagenic impurity assessment of Ixaconazole Impurity31 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Ixaconazole Impurity31 and acceptable intake and limit justification for Ixaconazole Impurity31. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Ixaconazole Impurity31

Explore Altox services and software through the Altox Pharma-Hub.